Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer.
暂无分享，去创建一个
Yi-long Wu | M. Satouchi | Ryohei Katayama | S. Yano | M. Nishio | M. Nakada | K. Fukuda | H. Taniguchi | S. Takeuchi | S. Nanjo | H. Nishihara | T. Kumagai | K. Yamashita | S. Arai | Azusa Tanimoto | A. Nishiyama | Takushi Yamamoto | M. Zheng | Koshiro Ohtsubo